BioVectra Inc.
Registration:
8
of
13
(2020-11-20
to
2021-04-29)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Valana Deighan,
General Counsel
-
Heather Delage,
VP, Business Development
-
Scott Doncaster,
VP, Manufacturing Technologies & Engineering
-
David Long,
Chief Financial Officer
-
Marc Sauer,
Vice President, Research and Development
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Oliver Technow,
Chief Executive Officer
- Date Modified: